Mandibular advancement therapy does not reduce inflammatory and metabolic biomarkers in patients with severe OSA: a randomized controlled trial
W. Trzepizur (Angers, France), S. Recoquillon (Angers, France), J. Pépin (Grenoble, France), B. Vielle (Angers, France), V. Bironneau (Poitiers, France), F. Chouet-Girard (Le Mans, France), S. Launois (Paris, France), N. Meslier (Angers, France), J. Meurice (Poitiers, France), X. Nguyen (Paris, France), A. Paris (Le Mans, France), P. Priou (Angers, France), R. Tamisier (Grenoble, France), F. Goupil (Le Mans, France), B. Fleury (Paris, France), F. Gagnadoux (Angers, France)
Source: International Congress 2018 – Upper airways morphology and diagnostics, and the challenges associated with mandibular advancement
Disease area: Sleep and breathing disorders
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
W. Trzepizur (Angers, France), S. Recoquillon (Angers, France), J. Pépin (Grenoble, France), B. Vielle (Angers, France), V. Bironneau (Poitiers, France), F. Chouet-Girard (Le Mans, France), S. Launois (Paris, France), N. Meslier (Angers, France), J. Meurice (Poitiers, France), X. Nguyen (Paris, France), A. Paris (Le Mans, France), P. Priou (Angers, France), R. Tamisier (Grenoble, France), F. Goupil (Le Mans, France), B. Fleury (Paris, France), F. Gagnadoux (Angers, France). Mandibular advancement therapy does not reduce inflammatory and metabolic biomarkers in patients with severe OSA: a randomized controlled trial. 5372
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Targeting treatable traits in severe asthma: a randomised controlled trial Source: Eur Respir J, 55 (3) 1901509; 10.1183/13993003.01509-2019 Year: 2020
The role of CPAP treatment in elderly patients with moderate obstructive sleep apnoea: a multicentre randomised controlled trial Source: Eur Respir J, 54 (2) 1900518; 10.1183/13993003.00518-2019 Year: 2019
Exacerbation action plans for patients with COPD and comorbidities: a randomised controlled trial Source: Eur Respir J, 54 (5) 1802134; 10.1183/13993003.02134-2018 Year: 2019
Antiplatelet therapy in the primary prevention of cardiovascular disease in patients with chronic obstructive pulmonary disease: a randomised controlled proof-of-concept trial Source: ERJ Open Res, 5 (3) 00110-2019; 10.1183/23120541.00110-2019 Year: 2019
Evidence generation for the clinical impact of myCOPD in patients with mild, moderate and newly diagnosed COPD: a randomised controlled trial Source: ERJ Open Res, 6 (4) 00460-2020; 10.1183/23120541.00460-2020 Year: 2020
Do marker states improve measurement properties of utility instruments: a randomized multi-center trial in patients with chronic respiratory disease Source: Eur Respir J 2004; 24: Suppl. 48, 295s Year: 2004
Factors affecting patients’ decision to adjust treatment; secondary analysis of a randomised trial of treatment optimisation in patients with severe asthma Source: Virtual Congress 2021 – Asthma burden and management I Year: 2021
Using placebo-controlled trials to define predictors of future exacerbations in severe asthma patients Source: Eur Respir J, 58 (6) 2101702; 10.1183/13993003.01702-2021 Year: 2021
Late Breaking Abstract - First-time assessment of efficacy of candidate vaccine to prevent acute exacerbations of chronic obstructive pulmonary disease (AECOPD): multicentre, randomised, controlled, observer-blind phase 2b trial Source: Virtual Congress 2021 – ALERT: COPD Year: 2021
Effects of suboptimal adherence of CPAP therapy on symptoms of obstructive sleep apnoea: a randomised, double-blind, controlled trial Source: Eur Respir J, 55 (3) 1901526; 10.1183/13993003.01526-2019 Year: 2020
Acupuncture improves nutritional status and BODE index in patients with chronic obstructive pulmonary disease: A randomized, placebo-controlled trial Source: Annual Congress 2011 - COPD management Year: 2011
Economic arguments in favor of immediate management of patients with moderate-to-severe obstructive sleep apnea syndrome. A randomised controlled trial Source: Eur Respir J 2003; 22: Suppl. 45, 353s Year: 2003
A randomised clinical trial of feedback on inhaler adherence and technique in patients with severe uncontrolled asthma Source: Eur Respir J, 51 (1) 1701126; 10.1183/13993003.01126-2017 Year: 2018
AVAPS-AE vs. ST mode: A randomised controlled trial in patients with obesity hypoventilation syndrome Source: International Congress 2018 – New insights in the management of chronic respiratory failure Year: 2018
A randomised, double-blind, crossover, placebo-controlled trial of a mandibular advancement device for the treatment of snoring and mild obstructive sleep apnoea-hypopnoea syndrome Source: Eur Respir J 2002; 20: Suppl. 38, 102s Year: 2002
Tele-assistance in chronic respiratory failure patients: a randomised clinical trial Source: Annual Congress 2008 - Integrated care and long-term strategies Year: 2008
Long-term efficacy of a home-based airway clearance programme to improve cough severity in patients with bronchiectasis:a randomised controlled trial> Source: International Congress 2019 – Advances in bronchiectasis and non-TB mycobacterial infections Year: 2019
A prospective randomised double-blind placebo controlled trial of venlafaxine in patients with stable chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2006; 28: Suppl. 50, 32s Year: 2006
CPAP impact on memory processes in OSA patients, a randomized sham controlled trial Source: International Congress 2016 – Treatment options for obstructive sleep apnoea and obesity hypoventilation Year: 2016
Telemetrically triggered interventions in the first month of cpap treatment - A prospective, randomized controlled intervention trial in patients with a new diagnosis of obstructive sleep apnea syndrome Source: International Congress 2016 – Treatment options for obstructive sleep apnoea and obesity hypoventilation Year: 2016